Loading company…
Virica Biotech develops small molecule enhancers for cell and gene therapy and vaccine manufacturing.
Founded in 2018 and based in Ottawa, Canada, Virica Biotech develops Viral Sensitizers (VSE™) to improve viral vector production for therapies and vaccines. Its customers include cell and gene therapy manufacturers and vaccine producers. In October 2021, it raised an undisclosed amount in Series A funding led by Dynamk Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in